1. Home
  2. SII vs AVDL Comparison

SII vs AVDL Comparison

Compare SII & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
  • AVDL
  • Stock Information
  • Founded
  • SII 2008
  • AVDL 2015
  • Country
  • SII Canada
  • AVDL Ireland
  • Employees
  • SII N/A
  • AVDL N/A
  • Industry
  • SII Finance: Consumer Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SII Finance
  • AVDL Health Care
  • Exchange
  • SII Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • SII 1.1B
  • AVDL 900.2M
  • IPO Year
  • SII N/A
  • AVDL 1996
  • Fundamental
  • Price
  • SII $70.87
  • AVDL $9.54
  • Analyst Decision
  • SII
  • AVDL Strong Buy
  • Analyst Count
  • SII 0
  • AVDL 6
  • Target Price
  • SII N/A
  • AVDL $18.17
  • AVG Volume (30 Days)
  • SII 164.0K
  • AVDL 1.6M
  • Earning Date
  • SII 08-06-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • SII 1.62%
  • AVDL N/A
  • EPS Growth
  • SII 10.23
  • AVDL N/A
  • EPS
  • SII 1.93
  • AVDL N/A
  • Revenue
  • SII $180,474,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • SII $0.57
  • AVDL $56.88
  • Revenue Next Year
  • SII $8.89
  • AVDL $29.81
  • P/E Ratio
  • SII $36.73
  • AVDL N/A
  • Revenue Growth
  • SII 17.97
  • AVDL 252.64
  • 52 Week Low
  • SII $38.41
  • AVDL $6.38
  • 52 Week High
  • SII $71.11
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • SII 73.31
  • AVDL 56.42
  • Support Level
  • SII $67.26
  • AVDL $8.74
  • Resistance Level
  • SII $70.51
  • AVDL $9.56
  • Average True Range (ATR)
  • SII 1.74
  • AVDL 0.39
  • MACD
  • SII -0.05
  • AVDL 0.04
  • Stochastic Oscillator
  • SII 98.43
  • AVDL 81.92

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: